Literature DB >> 8713684

Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH.

S L Elliott1, R J Ferris, A S Giraud, G A Cook, M V Skeljo, N D Yeomans.   

Abstract

1. There is good evidence that acid is a prerequisite for aspirin induced gastric mucosal damage; however, there is inconsistent information available for non-salicylate NSAID. The present study examines the effect of gastric luminal pH on indomethacin-induced gastric mucosal damage. 2. Macroscopic gastric mucosal damage induced by indomethacin (40 mg/kg) or vehicle, administered intraduodenally to male pylorus-ligated rats (n = 5-10/group), was assessed at four different levels of luminal pH (2,4,5.5 and 7) by means of digital planimetry. 3. There was a marked difference in the extent of damage induced by indomethacin at the different luminal pH levels (P = 0.001). There was no difference between the percentage of haemorrhagic lesions at pH 2 and 4 (P > 0.05), nor between pH 5.5 and 7 (P > 0.05). However, the damage at the high levels of luminal acidity (pH 2 and 4) was strikingly different from that at pH 5.5 and 7 (P < 0.05). 4. Gastric mucosal damage induced by indomethacin, a non-salicylate NSAID, is augmented by the presence of high concentration of acid in the gastric lumen. The main finding, that indomethacin injury is markedly less above pH 4, may have clinical implications in the prevention of NSAID-induced mucosal injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8713684     DOI: 10.1111/j.1440-1681.1996.tb02754.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  25 in total

1.  Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects.

Authors:  K Iijima; T Koike; N Ara; K Nakagawa; Y Kondo; K Uno; W Hatta; N Asano; A Imatani; T Shimosegawa
Journal:  J Gastroenterol       Date:  2014-06-22       Impact factor: 7.527

Review 2.  Lansoprazole: an update of its place in the management of acid-related disorders.

Authors:  A J Matheson; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Gastric acid secretion level modulates the association between Helicobacter pylori infection and low-dose aspirin-induced gastropathy.

Authors:  Katsunori Iijima; Nobuyuki Ara; Yasuhiko Abe; Tomoyuki Koike; Wataru Iwai; Kaname Uno; Naoki Asano; Akira Imatani; Shuichi Ohara; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2011-02-26       Impact factor: 7.527

Review 4.  NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management.

Authors:  Francis K L Chan
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.

Authors:  C J Hawkey; I Wilson; J Naesdal; G Långström; A J Swannell; N D Yeomans
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

6.  Prevention by parenteral aspirin of indomethacin-induced gastric lesions in rats: mediation by salicylic acid.

Authors:  Yusaku Komoike; Masanori Takeeda; Akiko Tanaka; Shinichi Kato; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

7.  Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.

Authors:  Koji Takeuchi; Akiko Tanaka; Yujiro Hayashi; Yoshiaki Kubo
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

Review 8.  Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.

Authors:  Kate McKeage; Stephanie K A Blick; Jamie D Croxtall; Katherine A Lyseng-Williamson; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  Clinical efficacy of esomeprazole in the prevention and healing of gastrointestinal toxicity associated with NSAIDs in elderly patients.

Authors:  Corrado Blandizzi; Marco Tuccori; Rocchina Colucci; Giovanni Gori; Matteo Fornai; Luca Antonioli; Narcisa Ghisu; Mario Del Tacca
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study.

Authors:  Harald E Vonkeman; Louise M A Braakman-Jansen; Rogier M Klok; Maarten J Postma; Jacobus R B J Brouwers; Mart A F J van de Laar
Journal:  Arthritis Res Ther       Date:  2008-12-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.